J.P. Morgan Initiates Salesforce at Overweight with $250 Price Target, Dismisses AI Concerns as "Overblown"
J.P. Morgan analyst Samik Chatterjee initiated coverage of Salesforce (CRM) with an Overweight rating and a December 2027 price target of $250 per share, upgrading the stock from a prior Not Rated status. The call, published August 13, 2026, hinges on the thesis that market anxiety surrounding Salesforce's competitive positioning in artificial intelligence is misplaced. Chatterjee described those concerns as "overblown," according to Yahoo Finance.
The rating shift from Not Rated to Overweight is a clean initiation rather than an incremental tick up a ladder. For a megacap enterprise software name that has traded under a cloud of skepticism around whether its AI monetization pipeline can keep pace with hyperscaler and pure-play competitors, the distinction matters. Chatterjee is not trimming estimates or nudging a target; he is laying down a fresh marker with a roughly 15-month horizon to December 2027 and a price objective that implies meaningful upside from levels the stock has inhabited through mid-2026.
The $250 target is the concrete anchor. Everything else in the note flows from whether investors should trust that number — and whether the "overblown" characterization of AI-related concerns holds up under scrutiny.
Salesforce has faced a recurring question from the sell-side and buy-side alike: can Agentforce and the broader Data Cloud ecosystem generate durable, incremental revenue, or will AI-native entrants and hyperscaler-embedded tools commoditize the layer where Salesforce has historically captured margin? Skeptics have pointed to elongated sales cycles for AI-powered SKUs, cannibalization risk between new agentic offerings and legacy seat-based licenses, and the possibility that large enterprises pilot rather than commit. Chatterjee's call directly contests that framing.
What "overblown" likely means in practical terms is that the discount the market has applied to Salesforce's AI revenue trajectory is too steep relative to what the installed base, distribution advantage, and existing data gravity can deliver. Salesforce is not starting from zero in AI. It is layering agentic capabilities atop a CRM footprint with deep enterprise penetration, and the bull case rests on cross-sell into accounts that already pay for Sales Cloud, Service Cloud, and Marketing Cloud. The friction of acquiring net-new AI spend is lower when the procurement relationship, the data integrations, and the user licenses already exist.
That said, a December 2027 target carries its own risks. It is a long-dated price objective, which gives the thesis considerable runway to be proven right but also means the call is insulated from near-term earnings volatility in a way that a 12-month target would not be. If Salesforce's FY2027 and FY2028 results disappoint on AI revenue contribution, a long-horizon target can be revised downward without ever having been "wrong" in a falsifiable sense. Investors weighing this call should treat the December 2027 date as a feature that reduces accountability pressure, not as a sign of high conviction in a specific near-term inflection.
The Overweight rating itself signals that J.P. Morgan expects CRM to outperform its coverage peers on a risk-adjusted basis over the investment horizon. That is a relative call, not an absolute one. In a software sector where multiples have compressed and re-expanded on every AI headline, outperforming peers could mean declining less in a risk-off tape rather than delivering absolute upside. The $250 target, however, is an absolute number, and investors should read the two together: Chatterjee is saying both that CRM will beat its peer set and that the stock will reach a specific price by a specific date.
The broader context here is the valuation gap that has opened between Salesforce and the AI infrastructure names that have captured the lion's share of investor enthusiasm. CRM has traded at a discount to its own historical software multiples and at a steep discount to the hyperscalers and semiconductor names driving the AI narrative. A bullish initiation from a top-tier bank does not close that gap on its own, but it does put a credible sell-side stamp on the argument that the discount is excessive.
For portfolio managers running enterprise software exposure, the actionable question is whether Chatterjee's "overblown" thesis aligns with their own diligence on Agentforce pipeline metrics, Data Cloud attach rates, and the competitive intensity from Microsoft Copilot and others in the CRM-adjacent AI layer. The note provides a framework and a price anchor; it does not substitute for that work.
For individual investors, the headline is simpler. A major Wall Street firm with a deep software franchise just told clients that Salesforce's AI story is better than the market thinks, and put a $250 price tag on that conviction. Whether that conviction is rewarded depends on execution over the next 15 months — and on whether the concerns Chatterjee calls "overblown" turn out to be premature rather than wrong.
